ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice

Cellular and Molecular Immunology

Volumn 17, Issue 2, 2020, Pages 163-177

  Deng, Tian ^a   Suo, Caixia ^b   Chang, Jiali ^b   Yang, Rui ^b   Li, Jingyu ^b   Cai, Ting ^b   Qiu, Ju ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Group 3 innate lymphoid cells; Intestinal immunity; OX40L; Regulatory T cells

Indexed keywords

CD134 ANTIGEN; INTERLEUKIN 7; OX40 LIGAND; POLYINOSINIC POLYCYTIDYLIC ACID; STAT5 PROTEIN; TUMOR NECROSIS FACTOR; HOMEODOMAIN PROTEIN; RAG-1 PROTEIN; TNFRSF4 PROTEIN, MOUSE; TNFSF15 PROTEIN, MOUSE; TNFSF4 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GROUP 3 INNATE LYMPHOID CELL; HOMEOSTASIS; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; INFLAMMATION; INTESTINE CELL; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN PROTEIN INTERACTION; RECOMBINATION-ACTIVATING GENE 1 KNOCKOUT MOUSE; REGULATORY T LYMPHOCYTE; UPREGULATION; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; COCULTURE; GENETICS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HOMEODOMAIN PROTEINS; HOMEOSTASIS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OX40 LIGAND; RECEPTORS, OX40; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 85061584145     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/s41423-019-0200-x     Document Type: Article

References (60)

1. Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647–675 (2012).
2. Diefenbach, A., Colonna, M. & Koyasu, S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 41, 354–365 (2014).
3. Cording, S., Medvedovic, J., Cherrier, M. & Eberl, G. Development and regulation of RORgt(+) innate lymphoid cells. FEBS Lett. 588, 4176–4181 (2014).
4. Montaldo, E., Juelke, K. & Romagnani, C. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice. Eur. J. Immunol. 45, 2171–2182 (2015).
5. Zhang, Y. et al. Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation. Cell. Mol. Immunol. 15, 697–709 (2018).
6. van de Pavert, S. A. & Vivier, E. Differentiation and function of group 3 innate lymphoid cells, from embryo to adult. Int. Immunol. 28, 35–42 (2016).
7. Hepworth, M. R. et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113–117 (2013).
8. + T cells. Science 348, 1031–1035 (2015).
9. Oliphant, C. J. et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41, 283–295 (2014).
10. Kim, M.-Y. et al. CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 18, 643–654 (2003).
11. Withers, D. R. et al. Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue. J. Immunol. 189, 2094–2098 (2012).
12. Hatfield, J. K. & Brown, M. A. Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE. Cell. Immunol. 297, 69–79 (2015).
13. Chang, J. H. et al. The chronicity of tonsillitis is significantly correlated with an increase in an LTi cell portion. Inflammation 37, 132–141 (2014).
14. − OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues. Eur. J. Immunol. 41, 1563–1572 (2011).
15. Kim, M. Y. et al. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J. Immunol. 174, 6686–6691 (2005).
16. Kim, M.-Y. et al. Neonatal and adult CD4+CD3− cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 177, 3074–3081 (2006).
17. Croft, M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 28, 57–78 (2010).
18. Chen, A. I. et al. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity 11, 689–698 (1999).
19. Griseri, T., Asquith, M., Thompson, C. & Powrie, F. OX40 is required for regulatory T cell-mediated control of colitis. J. Exp. Med. 207, 699–709 (2010).
20. Rudensky, A. Y. Regulatory T cells and Foxp3. Immunol. Rev. 241, 260–268 (2011).
21. Chaudhry, A. & Rudensky, A. Y. Control of inflammation by integration of environmental cues by regulatory T cells. J. Clin. Invest. 123, 939–944 (2013).
22. Takeda, I. et al. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172, 3580–3589 (2004).
23. Kumar P., et al. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation. Cell. Mol. Immunol. 16, 138–153 (2019).
24. Korn, L. L. et al. Conventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells. Mucosal Immunol. 7, 1045–1057 (2014).
25. Klose, C. S. et al. A T-bet gradient controls the fate and function of CCR6-RORgt+ innate lymphoid cells. Nature 494, 261–265 (2013).
26. Sawa, S. et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330, 665–669 (2010).
27. Eberl, G. et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64–73 (2004).
28. Wirtz, S. et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12, 1295–1309 (2017).
29. Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309–318 (2006).
30. Pearson, C. et al. ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation. eLife 5, e10066 (2016).
31. + mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 211, 1571–1583 (2014).
32. Strober, W. & Fuss, I. J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1756–1767 (2011).
33. Mills, K. H. TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11, 807–822 (2011).
34. Shih, D. Q. et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur. J. Immunol. 39, 3239–3250 (2009).
35. Ramnath, D., Powell, E. E., Scholz, G. M. & Sweet, M. J. The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair. Semin. Cell. Dev. Biol. 61, 22–30 (2017).
36. Levitzki, A. Targeting the immune system to fight cancer using chemical receptor homing vectors carrying polyinosine/cytosine (PolyIC). Front. Oncol. 2, 4 (2012).
37. Mosallanejad, K. et al. The DEAH-box RNA helicase DHX15 activates NF-kB and MAPK signaling downstream of MAVS during antiviral responses. Sci. Signal. 7, ra40 (2014).
38. Pobezinskaya, Y. L., Choksi, S., Morgan, M. J., Cao, X. & Liu, Z. G. The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling. J. Immunol. 186, 5212–5216 (2011).
39. Xiao, S. et al. Small-molecule RORgt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity 40, 477–489 (2014).
40. Mulero, M. C. et al. Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity. J. Biol. Chem. 284, 9394–9401 (2009).
41. Song, H., Wang, R., Wang, S. & Lin, J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc. Natl Acad. Sci. USA 102, 4700–4705 (2005).
42. Leonard, W. J. et al. Signaling via the IL-2 and IL-7 receptors from the membrane to the nucleus. Cold Spring Harb. Symp. Quant. Biol. 64, 417–424 (1999).
43. Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054–1066 (2018).
44. Hanash, A. M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339–350 (2012).
45. Goc, J. et al. Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer. Int Immunol. 28, 43–52 (2016).
46. Crellin, N. K. et al. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33, 752–764 (2010).
47. Kim, K. D. et al. Adaptive immune cells temper initial innate responses. Nat. Med. 13, 1248–1252 (2007).
48. Kim, S. H., Cho, B. H., Kiyono, H. & Jang, Y. S. Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches. Sci. Rep. 7, 3980 (2017).
49. Mortha, A. et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).
50. Xiao, X. et al. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo. J. Immunol. 181, 3193–3201 (2008).
51. So, T. & Croft, M. Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells. J. Immunol. 179, 1427–1430 (2007).
52. Zhang, X. et al. OX40 costimulation inhibits Foxp3 expression and Treg induction via BATF3-dependent and independent mechanisms. Cell Rep. 24, 607–618 (2018).
53. Vu, M. D. et al. OX40 costimulation turns off Foxp3+ Tregs. Blood 110, 2501–2510 (2007).
54. Ruby, C. E. et al. Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right. J. Immunol. 183, 4853–4857 (2009).
55. Kim, K. S. et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351, 858–863 (2016).
56. + T cells. Science 349, 989–993 (2015).
57. Halim, T. Y. F. et al. Tissue-restricted adaptive type 2 immunity is orchestrated by expression of the costimulatory molecule OX40L on group 2 innate lymphoid cells. Immunity 48, 1195–1207 e1196 (2018).
58. Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92–104 (2012).
59. Guo, X. et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 40, 25–39 (2014).
60. Wang, Y. et al. Discovery of biaryl amides as potent, orally bioavailable, and CNS penetrant RORgt inhibitors. ACS Med. Chem. Lett. 6, 787–792 (2015).